- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/06 - Antiglaucoma agents or miotics
Patent holdings for IPC class A61P 27/06
Total number of patents in this class: 1693
10-year publication summary
|
54
|
49
|
79
|
90
|
91
|
117
|
104
|
88
|
115
|
62
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2337 |
131 |
| Santen Pharmaceutical Co., Ltd. | 600 |
75 |
| Nicox S.A. | 138 |
27 |
| Kowa Company, Ltd. | 1198 |
20 |
| Senju Pharmaceutical Co., Ltd. | 227 |
20 |
| Alcon, Inc. | 5464 |
17 |
| Regeneron Pharmaceuticals, Inc. | 4323 |
17 |
| The Regents of the University of California | 20059 |
15 |
| Alcon Research, Ltd. | 350 |
15 |
| Daiichi Sankyo Company, Limited | 1884 |
12 |
| Takeda Pharmaceutical Company Limited | 2705 |
10 |
| Bausch & Lomb Incorporated | 1104 |
10 |
| Eye Therapies LLC | 41 |
10 |
| Ono Pharmaceutical Co., Ltd. | 431 |
10 |
| Japan Tobacco Inc. | 3595 |
9 |
| Novartis AG | 10730 |
8 |
| Astellas Pharma Inc. | 1083 |
8 |
| Dainippon Sumitomo Pharma Co., Ltd. | 190 |
8 |
| Novaliq GmbH | 171 |
8 |
| Rohto Pharmaceutical Co., Ltd. | 385 |
8 |
| Other owners | 1255 |